INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 27 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $0 | – | 785 | -15.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 923 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 923 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 923 | -4.2% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 963 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | +100.0% | 963 | +11.6% | 0.00% | – |
Q2 2018 | $1,000 | – | 863 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVI Holdings, LLC | 156,655 | $266,000 | 0.33% |
Stonepine Capital Management, LLC | 77,900 | $132,000 | 0.08% |
Anson Funds Management LP | 54,450 | $93,000 | 0.06% |
SABBY MANAGEMENT, LLC | 169,661 | $288,000 | 0.04% |
IMS Capital Management | 24,916 | $42,000 | 0.03% |
Paulson Wealth Management Inc. | 11,250 | $4,000 | 0.00% |
WEDBUSH SECURITIES INC | 16,250 | $28,000 | 0.00% |
PEDDOCK CAPITAL ADVISORS, LLC | 1 | $0 | 0.00% |
UBS Group AG | 1,813 | $3,000 | 0.00% |
MARINO, STRAM & ASSOCIATES LLC | 2 | $0 | 0.00% |